Cell-penetrating peptide (CPP);
Penetratin;
Octaarginine;
Insulin;
Nasal absorption;
DRUG-DELIVERY;
PROTEIN TRANSDUCTION;
TAT PROTEIN;
IN-VITRO;
MECHANISMS;
MEMBRANE;
DNA;
INTERNALIZATION;
EFFICACY;
HIV-1;
D O I:
10.1016/j.jconrel.2008.09.076
中图分类号:
O6 [化学];
学科分类号:
0703 ;
摘要:
The goal of this Study was to evaluate whether cell-penetrating peptides (CPPs) affect the nasal absorption of insulin. L- or D-forms of penetratin, or the L- or D-forms of octaarginine (L- or D-R8), was used as first time for nasal insulin delivery. Furthermore, the concentration of lactate dehydrogenase (LDH) in nasal lavage fluid was determined and a histopathological study of nasal respiratory epithelium was conducted. CPPs dramatically increased nasal insulin absorption, and it was more pronounced for L- and D-penetratin than L- or D-R8. L-penetratin was the most effective promoter of insulin absorption compared with others CPPs. A dose-dependent relationship of L-penetratin and insulin bioavailability was statically significant. The pharmacological availability and bioavailability of nasally administered insulin Was LIP to 76.7% and 50.7% relative to the Subcutaneous route, respectively. In contrast, increasing the D-penetratin concentration decreased the efficiency of nasal insulin absorption. There was no significant difference ill the release of LDH in nasal lavage fluid and the integrity of nasal respiratory epithelium when L-penetratin was present. In conclusion. these data demonstrate that L-penetratin markedly increased the permeability of insulin across the nasal membrane without Causing detectable damage to the integrity of cells in the nasal respiratory mucosa. (K) 2008 Elsevier B.V. All rights reserved.
机构:
Kobe Gakuin Univ, Fac Pharmaceut Sci, Lab Drug Delivery Syst, Kobe, Hyogo 6508586, Japan
Suez Canal Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Ismailia, EgyptKobe Gakuin Univ, Fac Pharmaceut Sci, Lab Drug Delivery Syst, Kobe, Hyogo 6508586, Japan
Khafagy, El-Sayed
论文数: 引用数:
h-index:
机构:
Kamei, Noriyasu
Nielsen, Ebbe Juel Bech
论文数: 0引用数: 0
h-index: 0
机构:
Kobe Gakuin Univ, Fac Pharmaceut Sci, Lab Drug Delivery Syst, Kobe, Hyogo 6508586, Japan
Novo Nordisk AS, Malov, DenmarkKobe Gakuin Univ, Fac Pharmaceut Sci, Lab Drug Delivery Syst, Kobe, Hyogo 6508586, Japan
Nielsen, Ebbe Juel Bech
Nishio, Reiji
论文数: 0引用数: 0
h-index: 0
机构:
Toray Industries Ltd, New Frontiers Res Labs, Kamakura, Kanagawa, JapanKobe Gakuin Univ, Fac Pharmaceut Sci, Lab Drug Delivery Syst, Kobe, Hyogo 6508586, Japan
机构:
Kobe Gakuin Univ, Lab Drug Delivery Syst, Fac Pharmaceut Sci, Chuo Ku, 1-1-3 Minatojima, Kobe, Hyogo 6508586, Japan
Novo Nordisk AS, DK-2760 Malov, DenmarkKobe Gakuin Univ, Lab Drug Delivery Syst, Fac Pharmaceut Sci, Chuo Ku, 1-1-3 Minatojima, Kobe, Hyogo 6508586, Japan
Nielsen, Ebbe Juel Bech
Khafagy, El-Sayed
论文数: 0引用数: 0
h-index: 0
机构:
Suez Canal Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, Ismailia, EgyptKobe Gakuin Univ, Lab Drug Delivery Syst, Fac Pharmaceut Sci, Chuo Ku, 1-1-3 Minatojima, Kobe, Hyogo 6508586, Japan
机构:
Ctr Genet Engn & Biotechnol, Biomed Res Div, Peptide Synth Lab, Havana 10600, CubaCtr Genet Engn & Biotechnol CIGB, Vaccine Dept, Biomed Res Div, Havana 10600, Cuba
Garay, Hilda
Perera, Yasser
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Genet Engn & Biotechnol, Pharmaceut Dept, Biomed Res Div, Mol Oncol Grp, Havana 10600, Cuba
Yongzhou Zhong Gu Biotechnol Co Ltd, China Cuba Biotechnol Joint Innovat Ctr CCBJIC, Yongzhou City 425000, Hunan, Peoples R ChinaCtr Genet Engn & Biotechnol CIGB, Vaccine Dept, Biomed Res Div, Havana 10600, Cuba
Perera, Yasser
Yang, Ke
论文数: 0引用数: 0
h-index: 0
机构:
Yongzhou Zhong Gu Biotechnol Co Ltd, China Cuba Biotechnol Joint Innovat Ctr CCBJIC, Yongzhou City 425000, Hunan, Peoples R ChinaCtr Genet Engn & Biotechnol CIGB, Vaccine Dept, Biomed Res Div, Havana 10600, Cuba